A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

Evanthia Galanis, S. Keith Anderson, Erin L. Twohy, Xiomara W. Carrero, Jesse G. Dixon, David Dinh Tran, Suriya A. Jeyapalan, Daniel M. Anderson, Timothy J. Kaufmann, Ryan W. Feathers, Caterina Giannini, Jan C. Buckner, Panos Z. Anastasiadis, David Schiff

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872'. Together they form a unique fingerprint.

Medicine & Life Sciences